However, some studies have shown that administrating FGF21 prevents diet-induced obesity and insulin resistance in mice and humans (Fisher and Maratos-Flier, 2016; Staiger et al., 2017). The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.